Literature DB >> 18247153

Competition for proline between indigenous Escherichia coli and E. coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157:H7.

Yoshika Momose1, Kazuhiro Hirayama, Kikuji Itoh.   

Abstract

Previously, we produced two groups of gnotobiotic mice, GB-3 and GB-4, which showed different responses to Escherichia coli O157:H7 challenge. E. coli O157:H7 was eliminated from GB-3, whereas GB-4 mice became carriers. It has been reported that the lag time of E. coli O157:H7 growth in 50% GB-3 caecal suspension was extended when compared to GB-4 caecal suspension. In this study, competition for nutrients between intestinal microbiota of GB-3 and GB-4 mice and E. coli O157:H7 was examined. Amino acid concentrations in the caecal contents of GB-3 and GB-4 differed, especially the concentration of proline. The supplementation of proline into GB-3 caecal suspension decreased the lag time of E. coli O157:H7 growth in vitro. When E. coli O157:H7 was cultured with each of the strains used to produce GB-3 mice in vitro, 2 strains of E. coli (proline consumers) out of 5 enterobacteriaceae strains strongly suppressed E. coli O157:H7 growth and the suppression was attenuated by the addition of proline into the medium. These results indicate that competition for proline with indigenous E. coli affected the growth of E. coli O157:H7 in vivo and may contribute to E. coli O157:H7 elimination from the intestine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18247153     DOI: 10.1007/s10482-008-9222-6

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  23 in total

1.  Comparing the microbiota of the cystic fibrosis lung and human gut.

Authors:  Geraint B Rogers; Mary P Carroll; Lucas R Hoffman; Alan W Walker; David A Fine; Kenneth D Bruce
Journal:  Gut Microbes       Date:  2010-01-29

Review 2.  Role of the gut microbiota in immunity and inflammatory disease.

Authors:  Nobuhiko Kamada; Sang-Uk Seo; Grace Y Chen; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2013-05       Impact factor: 53.106

3.  Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease.

Authors:  Olga C Aroniadis; Lawrence J Brandt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-04

4.  Biocontrol activity of a cold-adapted yeast from Tibet against gray mold in cherry tomato and its action mechanism.

Authors:  Hao Hu; Michael E Wisniewski; Ahmed Abdelfattah; Xiaodong Zheng
Journal:  Extremophiles       Date:  2017-06-08       Impact factor: 2.395

5.  Enteric Pathogens Exploit the Microbiota-generated Nutritional Environment of the Gut.

Authors:  Alline R Pacheco; Vanessa Sperandio
Journal:  Microbiol Spectr       Date:  2015-06

Review 6.  No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogens.

Authors:  Martina Sassone-Corsi; Manuela Raffatellu
Journal:  J Immunol       Date:  2015-05-01       Impact factor: 5.422

Review 7.  Control of pathogens and pathobionts by the gut microbiota.

Authors:  Nobuhiko Kamada; Grace Y Chen; Naohiro Inohara; Gabriel Núñez
Journal:  Nat Immunol       Date:  2013-07       Impact factor: 25.606

Review 8.  Role of Proline in Pathogen and Host Interactions.

Authors:  Shelbi L Christgen; Donald F Becker
Journal:  Antioxid Redox Signal       Date:  2018-02-02       Impact factor: 8.401

Review 9.  Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection.

Authors:  Q R Ducarmon; R D Zwittink; B V H Hornung; W van Schaik; V B Young; E J Kuijper
Journal:  Microbiol Mol Biol Rev       Date:  2019-06-05       Impact factor: 11.056

Review 10.  Gut microbiota as potential orchestrators of irritable bowel syndrome.

Authors:  Sean M P Bennet; Lena Ohman; Magnus Simren
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.